183 related articles for article (PubMed ID: 8368716)
1. [Treatment of hypereosinophilic syndromes of myeloproliferative expression with the combination of hydroxyurea and interferon alpha. Apropos of 7 cases].
Coutant G; Blétry O; Prin L; Hauteville D; de Puyfontaine O; Abgrall JF; Godeau P
Ann Med Interne (Paris); 1993; 144(4):243-50. PubMed ID: 8368716
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of alpha interferon and hydroxyurea in late phase refractory myeloproliferative disease.
Litam PP; Landaw SA; Zamkoff KW
Haematologia (Budap); 1994; 26(2):87-90. PubMed ID: 7890266
[TBL] [Abstract][Full Text] [Related]
3. [Interferon-alpha therapy in the myeloproliferative variants of hypereosinophilic syndrome].
Kobayashi M; Katayama T; Ochiai S; Yoshida M; Kaito K; Masuoka H; Shimada T; Nishiwaki K; Sakai O
Rinsho Ketsueki; 1993 Mar; 34(3):367-72. PubMed ID: 8479090
[TBL] [Abstract][Full Text] [Related]
4. Treatment of hypereosinophilic syndromes with prednisone, hydroxyurea, and interferon.
Butterfield JH
Immunol Allergy Clin North Am; 2007 Aug; 27(3):493-518. PubMed ID: 17868861
[TBL] [Abstract][Full Text] [Related]
5. [Alpha interferon treatment in idiopathic hypereosinophilic syndrome resistant to conventional therapy].
Esteve J; Cervantes F; Bosch F; Cobo F; Montserrat E; Rozman C
Med Clin (Barc); 1996 Mar; 106(8):304-6. PubMed ID: 8667689
[TBL] [Abstract][Full Text] [Related]
6. Idiopathic hypereosinophilic syndrome and "eosinophilic leukemia".
Cassi E; De Paoli A; Fava S; Luoni M; Tosi A; Turri C; Grimi E
Haematologica; 1992; 77(5):430-2. PubMed ID: 1483595
[TBL] [Abstract][Full Text] [Related]
7. Mucosal ulcerations revealing primitive hypereosinophilic syndrome.
Barouky R; Bencharif L; Badet F; Salles G; Vital Durand D; Rousset H
Eur J Dermatol; 2003; 13(2):207-8. PubMed ID: 12695143
[TBL] [Abstract][Full Text] [Related]
8. Acute leukemia and myelodysplasia in patients with a Philadelphia chromosome negative chronic myeloproliferative disorder treated with hydroxyurea alone or with hydroxyurea after busulphan.
Nielsen I; Hasselbalch HC
Am J Hematol; 2003 Sep; 74(1):26-31. PubMed ID: 12949887
[TBL] [Abstract][Full Text] [Related]
9. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
Nand S; Stock W; Godwin J; Fisher SG
Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610
[TBL] [Abstract][Full Text] [Related]
10. [Isolated mucosal ulcers disclosing idiopathic hypereosinophilic syndrome].
Billon C; Gautier C; Villaret E; Ducos MH; Martin JC; Geniaux M
Ann Dermatol Venereol; 1997; 124(3):248-50. PubMed ID: 9686058
[TBL] [Abstract][Full Text] [Related]
11. [Hypereosinophilia syndrome. Apropos of 2 cases and literature review].
Straetmans N; Ferrant A; Martiat P; Sokal G; Michaux JL
Acta Clin Belg; 1992; 47(2):90-9. PubMed ID: 1321541
[TBL] [Abstract][Full Text] [Related]
12. Case report: rapid and complete control of idiopathic hypereosinophilia with imatinib mesylate.
Schaller JL; Burkland GA
MedGenMed; 2001 Sep; 3(5):9. PubMed ID: 11698916
[TBL] [Abstract][Full Text] [Related]
13. The hypereosinophilic syndrome: dramatic response to therapeutic intervention.
Parrillo JE; Fauci AS; Wolff SM
Trans Assoc Am Physicians; 1977; 90():135-44. PubMed ID: 611659
[TBL] [Abstract][Full Text] [Related]
14. Hypereosinophilic syndrome associated with polycythemia vera.
Varon D; Wetzler M; Berrebi A
Arch Intern Med; 1986 Jul; 146(7):1440-1. PubMed ID: 3718142
[TBL] [Abstract][Full Text] [Related]
15. Thrombotic microangiopathy associated with interferon therapy for patients with chronic myelogenous leukemia: coincidence or true side effect?
Ravandi-Kashani F; Cortes J; Talpaz M; Kantarjian HM
Cancer; 1999 Jun; 85(12):2583-8. PubMed ID: 10375106
[TBL] [Abstract][Full Text] [Related]
16. [Hypereosinophilic syndrome in acute lymphatic leukemia].
Nadal D; Plüss HJ; Jörg W; Hitzig WH
Schweiz Med Wochenschr; 1986 Aug; 116(34):1151-4. PubMed ID: 3464089
[TBL] [Abstract][Full Text] [Related]
17. Toxicity and side effects of hydroxyurea used for primary thrombocythemia.
Randi ML; Ruzzon E; Tezza F; Luzzatto G; Fabris F
Platelets; 2005; 16(3-4):181-4. PubMed ID: 16011962
[TBL] [Abstract][Full Text] [Related]
18. Idiopathic hypereosinophilic syndrome: a report of four cases in Arabs, and a review of the literature.
George BO; Abdelaal MA; Gangi MT; Kinsara AJ
Afr J Med Med Sci; 2001 Sep; 30(3):241-9. PubMed ID: 14510138
[TBL] [Abstract][Full Text] [Related]
19. Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders.
Cortes J; Giles F; O'Brien S; Thomas D; Albitar M; Rios MB; Talpaz M; Garcia-Manero G; Faderl S; Letvak L; Salvado A; Kantarjian H
Cancer; 2003 Jun; 97(11):2760-6. PubMed ID: 12767088
[TBL] [Abstract][Full Text] [Related]
20. [Chronic myeloid leukemia].
Hehlmann R
Ther Umsch; 1996 Feb; 53(2):82-7. PubMed ID: 8629268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
